Today: 12 June 2026
Browse Category

NASDAQ:OPCH 13 January 2026 - 30 April 2026

Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

Option Care Health shares fell 28% to $19.44 after the company cut its 2026 revenue forecast and reported first-quarter sales of $1.35 billion, missing estimates. The company now expects 2026 revenue of $5.675–$5.775 billion, down from a prior range of $5.8–$6.0 billion, citing pressure in its chronic inflammatory disease portfolio. Adjusted profit guidance was unchanged.
30 April 2026
·
Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

Option Care Health shares rose nearly 10% to $35.16 Tuesday after the company released preliminary Q4 results and doubled its share buyback authorization to $1.0 billion. The company projects Q4 net revenue of $1.46–$1.47 billion and adjusted EPS of $0.46–$0.49. A Citizens analyst raised the price target to $38, citing easing Stelara-related risk after 2026.
13 January 2026
··

Stock Market Today

  • Hays Shares See Slight Fair Value Reduction as Analysts Reassess Outlook
    June 11, 2026, 10:59 PM EDT. Hays (LSE:HAS) experienced a modest fair value cut from £0.42 to £0.41 amid cautious analyst sentiment. RBC Capital remains optimistic, highlighting Hays' global reach and diversified client base as potential upside drivers if hiring activity stabilizes. However, Citi downgraded the stock, citing concerns over execution and revenue trends, leading to questions about the company's ability to convert fees into steady earnings. Recent leadership changes include the appointment of Mark Dearnley as CEO, who brings extensive digital transformation experience. The downward adjustment also reflects a slightly weaker revenue growth forecast, now expected to decline by 2.17%. Analysts' mixed views underscore ongoing valuation risks and uncertainty in Hays' near-term outlook.

Latest articles

AI Names Drop, Oil Upends Inflation Bets, US Stocks Slip

Dow up 930 points after hours as tech lifts Nasdaq

12 June 2026
Dow soars 929.97 points for its strongest session in months as easing geopolitical risk and a rebound in tech drive ETFs higher after hours; chip stocks surge with the PHLX Semiconductor Index up 7.9%, while Adobe drops 5.44% after CFO exit despite raised forecasts.
Keel Infrastructure (KEEL) shares surge after $458 million AI data center deal closes

Keel Infrastructure (KEEL) shares surge after $458 million AI data center deal closes

12 June 2026
Keel Infrastructure Corp. surged 5.14% to $5.52 after closing $458 million in 1.250% convertible senior notes due 2032, with proceeds aimed at accelerating AI and high-performance computing data center projects; the notes’ initial conversion price is $7.41, about 25% above the June 4 close, while analysts’ 12-month price targets range from $3.00 to $8.00, averaging $5.52.
Go toTop